Related Experiment Videos
Yassin El Mourabit1, Mohammed Tribak1, Hasna Leghlimi2
1Service de chirurgie cardiovasculaire B, Hôpital Ibn Sina, Université Med V, Rabat, 1005, Maroc.
Summary
Coronary artery bypass grafting (CABG) in patients under 45 offers excellent long-term survival and improved quality of life. This study confirms CABG is a safe and effective treatment for young adults with coronary artery disease.
Area of Science:
- Cardiology
- Cardiac Surgery
- Vascular Medicine
Context:
- Coronary artery disease (CAD) in young patients (<45 years) presents unique challenges.
- Coronary artery bypass grafting (CABG) is the preferred revascularization strategy for this demographic.
- Understanding outcomes in young CABG patients is crucial for long-term management.
Purpose:
- To characterize the patient profile undergoing CABG at a young age.
- To evaluate the short- and long-term outcomes of CABG in patients under 45.
- To assess quality of life and treatment adherence post-CABG.
Summary:
- A study of 130 young patients (under 45) undergoing CABG showed 1.53% hospital mortality and 24.61% postoperative morbidity.
- Long-term survival at 10 years was 89%, with 82.03% free from major cardiovascular events.
- Mean follow-up of 11 years revealed improved diabetes control (75.5%) and smoking cessation (82.7%), though symptoms persisted in some.
Impact:
- CABG in young patients demonstrates acceptable hospital risks and excellent long-term survival.
- The procedure leads to significant improvements in patients' quality of life.
- Findings support CABG as a viable and beneficial treatment for early-onset coronary artery disease.